1. Home
  2. NVST vs BLTE Comparison

NVST vs BLTE Comparison

Compare NVST & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envista Holdings Corporation

NVST

Envista Holdings Corporation

HOLD

Current Price

$29.42

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$177.97

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVST
BLTE
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
NVST
BLTE
Price
$29.42
$177.97
Analyst Decision
Buy
Strong Buy
Analyst Count
14
8
Target Price
$24.85
$161.57
AVG Volume (30 Days)
3.4M
169.6K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
104.31
N/A
EPS
0.28
N/A
Revenue
$2,566,500,000.00
N/A
Revenue This Year
$6.67
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
$104.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.22
$49.00
52 Week High
$30.42
$200.00

Technical Indicators

Market Signals
Indicator
NVST
BLTE
Relative Strength Index (RSI) 66.47 50.29
Support Level $19.29 $168.00
Resistance Level $30.42 $200.00
Average True Range (ATR) 0.98 7.80
MACD -0.08 -0.44
Stochastic Oscillator 59.60 37.10

Price Performance

Historical Comparison
NVST
BLTE

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: